Literature DB >> 7579419

Stimulation of fetal hemoglobin production by short chain fatty acids.

E Liakopoulou1, C A Blau, Q Li, B Josephson, J A Wolf, B Fournarakis, V Raisys, G Dover, T Papayannopoulou, G Stamatoyannopoulos.   

Abstract

Butyrate, a four-carbon fatty acid, and its two-carbon metabolic product, acetate, are inducers of gamma-globin synthesis. To test whether other short-chain fatty acids share this property, we first examined whether propionic acid, a three-carbon fatty acid that is not catabolized to acetate, induces gamma-globin expression. Sodium propionate increased the frequency of fetal hemoglobin containing erythroblasts and the gamma/gamma + beta mRNA ratios in adult erythroid cell cultures and F reticulocyte production in a nonanemic juvenile baboon. Short-chain fatty acids containing five (pentanoic), six (hexanoic), seven (heptanoic), eight (octanoic), and nine (nonanoic) carbons induced gamma-globin expression (as measured by increase in gamma-positive erythroblasts and gamma/gamma + beta mRNA ratios) in adult erythroid burst-forming unit cultures. There was a clear-cut relationship between the concentration of fatty acids in culture and the degree of induction of gamma-globin expression. Three-, four-, and five-carbon fatty acids were better inducers of gamma globin in culture as compared with six- to nine-carbon fatty acids. These results suggest that all short-chain fatty acids share the property of gamma-globin gene inducibility. The fact that valproic acid, a derivative of pentanoic acid, also induces gamma-globin expression suggests that short-chain fatty acid derivatives that are already approved for human use may possess the property of gamma-globin inducibility and may be of therapeutic relevance to the beta-chain hemoglobinopathies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7579419

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  15 in total

1.  Induction of fetal hemoglobin by propionic and butyric acid derivatives: correlations between chemical structure and potency of Hb F induction.

Authors:  Effie Liakopoulou; Qiliang Li; George Stamatoyannopoulos
Journal:  Blood Cells Mol Dis       Date:  2002 Jul-Aug       Impact factor: 3.039

2.  Identification of novel small-molecule inducers of fetal hemoglobin using pharmacophore and 'PSEUDO' receptor models.

Authors:  Regine Bohacek; Michael S Boosalis; Colin McMartin; Douglas V Faller; Susan P Perrine
Journal:  Chem Biol Drug Des       Date:  2006-05       Impact factor: 2.817

3.  Induction of fetal globin in beta-thalassemia: Cellular obstacles and molecular progress.

Authors:  Susan P Perrine; Serguei A Castaneda; Michael S Boosalis; Gary L White; Brandon M Jones; Regine Bohacek
Journal:  Ann N Y Acad Sci       Date:  2005       Impact factor: 5.691

4.  Chemical genetic strategy identifies histone deacetylase 1 (HDAC1) and HDAC2 as therapeutic targets in sickle cell disease.

Authors:  James E Bradner; Raymond Mak; Shyam K Tanguturi; Ralph Mazitschek; Stephen J Haggarty; Kenneth Ross; Cindy Y Chang; Jocelyn Bosco; Nathan West; Elizabeth Morse; Katherine Lin; John Paul Shen; Nicholas P Kwiatkowski; Nele Gheldof; Job Dekker; Daniel J DeAngelo; Steven A Carr; Stuart L Schreiber; Todd R Golub; Benjamin L Ebert
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

5.  Inactivation of HDAC1 or HDAC2 induces gamma globin expression without altering cell cycle or proliferation.

Authors:  Erica B Esrick; Marie McConkey; Katherine Lin; Alyse Frisbee; Benjamin L Ebert
Journal:  Am J Hematol       Date:  2015-05-28       Impact factor: 10.047

6.  Pharmacological Induction of Human Fetal Globin Gene in Hydroxyurea-Resistant Primary Adult Erythroid Cells.

Authors:  Yu-Chi Chou; Ruei-Lin Chen; Zheng-Sheng Lai; Jen-Shin Song; Yu-Sheng Chao; Che-Kun James Shen
Journal:  Mol Cell Biol       Date:  2015-05-18       Impact factor: 4.272

7.  Short-chain fatty acid derivatives stimulate cell proliferation and induce STAT-5 activation.

Authors:  M S Boosalis; R Bandyopadhyay; E H Bresnick; B S Pace; K Van DeMark; B Zhang; D V Faller; S P Perrine
Journal:  Blood       Date:  2001-05-15       Impact factor: 22.113

8.  Sustained induction of fetal hemoglobin by pulse butyrate therapy in sickle cell disease.

Authors:  G F Atweh; M Sutton; I Nassif; V Boosalis; G J Dover; S Wallenstein; E Wright; L McMahon; G Stamatoyannopoulos; D V Faller; S P Perrine
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

9.  Liquid chromatography-mass spectrometric assay for quantitation of the short-chain fatty acid, 2,2-dimethylbutyrate (NSC 741804), in rat plasma.

Authors:  Robert A Parise; Jan H Beumer; Cyrous O Kangani; Julianne L Holleran; Julie L Eiseman; Nicola F Smith; Joseph M Covey; Susan P Perrine; Merrill J Egorin
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2007-12-08       Impact factor: 3.205

10.  Short-chain fatty acid derivatives induce fetal globin expression and erythropoiesis in vivo.

Authors:  Betty S Pace; Gary L White; George J Dover; Michael S Boosalis; Douglas V Faller; Susan P Perrine
Journal:  Blood       Date:  2002-08-15       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.